Please use this identifier to cite or link to this item:
|Title:||Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study||Authors:||Black, Emma;Bruno, Raimondo;Mammen, Kristie;Mills, Llewellyn;Siefried, Krista J;Deacon, Rachel M;Shakeshaft, Anthony;Dunlop, Adrian J;Ezard, Nadine;Montebello, Mark;Childs, Steven ;Reid, David;Holmes, Jennifer;Lintzeris, Nicholas||Affliation:||Central Coast Local Health District||Issue Date:||14-Jul-2023||Source:||Online ahead of print||Journal title:||The Medical journal of Australia||Department:||Drug & Alcohol||Abstract:||To investigate the demographic characteristics, substance use, and self-rated health of people entering treatment in New South Wales public health services for alcohol, amphetamine-type stimulants, cannabis, cocaine, or opioids use, by principal drug of concern. Baseline findings of a cohort study; analysis of data in patient electronic medical records and NSW minimum data set for drug and alcohol treatment services. People completing initial Australian Treatment Outcomes Profile (ATOP) assessments on entry to publicly funded alcohol and other drug treatment services in six NSW local health districts/networks, 1 July 2016 - 30 June 2019. Socio-demographic characteristics, and substance use and self-rated health (psychological, physical, quality of life) during preceding 28 days, by principal drug of concern. Of 14 087 people included in our analysis, the principal drug of concern was alcohol for 6051 people (43%), opioids for 3158 (22%), amphetamine-type stimulants for 2534 (18%), cannabis for 2098 (15%), and cocaine for 246 (2%). Most people commencing treatment were male (9373, 66.5%), aged 20-39 years (7846, 50.4%), and were born in Australia (10 934, 86.7%). Polysubstance use was frequently reported, particularly by people for whom opioids or amphetamine-type stimulants were the principal drugs of concern. Large proportions used tobacco daily (53-82%, by principal drug of concern group) and reported poor psychological health (47-59%), poor physical health (32-44%), or poor quality of life (43-52%). The prevalence of social disadvantage and poor health is high among people seeking assistance with alcohol, amphetamine-type stimulants, cannabis, cocaine, or opioids use problems. Given the differences in these characteristics by principal drug of concern, health services should collect comprehensive patient information during assessment to facilitate more holistic, tailored, and person-centred care.||URI:||https://hdl.handle.net/1/2381||DOI:||10.5694/mja2.52039||Pubmed:||https://pubmed.ncbi.nlm.nih.gov/37449648||Publicaton type:||Journal Article||Keywords:||Drug and Alcohol
|Study or Trial:||Cohort Study|
|Appears in Collections:||Mental Health|
Show full item record
checked on Oct 2, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.